Category Archives: GPhA urges Congress to repeal Medicaid rebate penalty

GPhA urges Congress to repeal Medicaid rebate penalty

The Generic Pharmaceutical Association (GPhA) sent a letter to the Chairmen and Ranking Members of the Senate Finance Committee and House Energy and Commerce Committee expressing deep concerns that the recently enacted Medicaid rebate penalty on generic drugs could drive up drug costs and hinder patient access to more affordable medicines. At issue is Section 602 of the Bipartisan Budget Act

Read more